MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.
SLXN
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Silexion Therapeutics (SLXN) Ownership - Who owns Silexion Therapeutics?

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.67M
P/E Ratio
N/A
Total Cash
1.7M
Projected Growth
N/A
Total Debt
116K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

SLXN
Capitalization
5.67M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
1.7M
Total Cash/Share
0.17
Total Debt
116K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-18.26M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.66
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
0.98
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-4.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-212.28
Shares Held By Institutions
N/A
Shares Outstanding - Current
9.77M
Total Liabilities
17.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-96.778
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details